Gibson Christopher

Gibson Christopher is listed in filings as Director at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX) and Pacific Biosciences of California, Inc. (PACB). The current snapshot covers public activity from Jan 13, 2025 to Jun 5, 2026. Reported amounts are shown as $144.8K to $123.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.